Martin Durisin

Martin Durisin

Auto-generated profile, based on publicly available information

Martin Durisin

Medizinische Hochschule Hannover, HNO, Hannover

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Otology & Neurotology
Verified
Journal Article
Closed access
HSHeike Schmitt
Heike Schmitt
ARAriane Roemer
Ariane Roemer
CZCarsten Zeilinger
Carsten Zeilinger
RSRolf Salcher
Rolf Salcher
MDMartin Durisin
Martin Durisin
AWAthanasia Warnecke
Athanasia Warnecke
Objective: Biomarkers reflecting the etiology and pathophysiology of inner ear diseases are limited. Evaluation of proteins in the perilymph may improve our understanding of inner ear disease. Heat shock proteins (HSP) belong to a superfamily of stress proteins and promote refolding of denatured proteins. The aim of the study was to analyze HSP in human perilymph and to identify possible correlation with audiological and etiologic data. Methods: Sampling of the perilymph was performed during cochlear implantation and vestibular schwannoma removal. Individual proteins were identified by a shot-gun proteomics approach by orbitrap mass spectrometry. Expression of HSP genes was determined in human cochlear tissue that was obtained during transcochlear surgeries. Results: Ten subgroups of HSP were identified in human perilymph samples. Increased levels of HSP were detected in a higher percentage in the perilymph of patients with residual hearing when compared with patients with no residual hearing in cochlear implantation. In patients with complete preservation of residual hearing, HSP 90 is identified in a lower percentage whereas HSP 70 1A/1B and 6 was identified in all the samples. Constitutive expression of HSP family members was verified in normal cochlear tissue. Conclusion: The 10 HSP variants are not identified in all the perilymph samples, but in a higher proportion in patients with residual hearing compared with patients with no residual hearing. In-depth proteome analysis of perilymph samples in correlation to patients’ audiogram data shows an increased concentration of HSP in patients with residual hearing. An increase in specific HSP in patients with loss of residual hearing after cochlear implantation was not observed.

1 May 2015 in Acta Biomaterialia
Verified
Journal Article
Closed access
CWConstantin M. Weber
Constantin M. Weber
RERainer Eifler
Rainer Eifler
JSJan-Marten Seitz
Jan-Marten Seitz
HMHans Maier
Hans Maier
JRJanin Reifenrath
Janin Reifenrath
MDMartin Durisin
Martin Durisin

25 May 2015 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
FIFriedrich Ihler
Friedrich Ihler
MKMario Koopmann
Mario Koopmann
BWBernhard G. Weiss
Bernhard G. Weiss
LDLeif Hendrik Dröge
Leif Hendrik Dröge
MDMartin Durisin
Martin Durisin
HWHendrik A. Wolff
Hendrik A. Wolff

15 July 2015 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
VHVictor Helmstaedter
Victor Helmstaedter
RTRalph Tellkamp
Ralph Tellkamp
OMOmid Majdani
Omid Majdani
AWAthanasia Warnecke
Athanasia Warnecke
TLThomas Lenarz
Thomas Lenarz
MDMartin Durisin
Martin Durisin

13 May 2021
Verified
Conference Paper
Open access
MDM Durisin
M Durisin
EME Makowski
E Makowski
HSH Schmitt
H Schmitt
JHJ Harre
J Harre
APAndreas Pich
Andreas Pich
TLThomas Lenarz
Thomas Lenarz
Introduction Proteome-based analysis of human perilymph during cochlear implantation could provide new avenues for future inner ear pharmacotherapies. The complement system relates to several soluble and membrane-bound factors that are regulating a variety of physiological and pathological processes. Their role in the inner ear, however, is not known yet. Methods Human perilymph is collected during cochlear implantation from patients with severe hearing loss. Mass spectrometry was utilized to detect the individual protein profile. Individual proteins were identified by a shot-gun proteomics approach and further analysis using orbitrap mass spectrometry (Thermo Fisher Scientific) and MaxQuant software for identification. Results Collection and analysis of 41 perilymph samples led to the identification of a plenitude of proteins. Several components of the complement system were among the identified proteins. Specifically, the neuroprotective complement factors C1q as well as C3a and C5a were present in human perilymph. Conclusion The detection neuroprotective complement factors in human perilymph is the initial step towards the in depth investigation of a new calls of biomolecules in the inner ear. Among the effects mediated by the neuroprotective complement factors, phosphorylation of CREB and the stabilization of the cell membrane via the regulation of cholesterol- and lipid metabolism could be relevant for the cochlea. Whether this will result in novel inner ear therapeutics is currently under investigation. Poster-PDF A-1427.pdf Publication Date: 13 May 2021 (online) © . Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

13 May 2021
Verified
Conference Paper
Open access
MDM Durisin
M Durisin
EME Makowski
E Makowski
HSH Schmitt
H Schmitt
JHJ Harre
J Harre
APA Pich
A Pich
TLT Lenarz
T Lenarz
Einleitung Proteom-basierte Analyse der humanen Perilymphe im Rahmen der Cochlea Implantation könnte neue Wege für künftige Pharmakotherapien des Innenohrs eröffnen. Das Complement-System besteht aus verschiedenen löslichen oder membrangebundenen Faktoren, die eine Vielzahl physiologischer und pathologischer Prozesse regulieren. Deren Rolle im Innenohr indes ist bislang nicht hinreichend untersucht. Methode Humane Perilymphe entnommen von Patienten während der Versorgung mit einem Cochlea Implantat wurde mittels Massenspektrometrie untersucht. Die Proteine werden anhand Shot-gun proteomics identifiziert (Orbitrap Massenspektrometer, Thermo Fisher Scientific) und über die MaxQuant Software quantifiziert. Resultate: Entnahme und Analyse von 41 Perilymphe-Proben während der Cochlea Implantation hochgradig schwerhöriger Patienten führte zur Identifizierung zahlreicher Proteine. Darunter fanden sich zahlreiche Faktoren des Komplement-Systems. Insbesondere die neuroprotektiven Complement-Faktoren C1q sowie C3a und C5a lassen sich in der Perilymphe nachweisen. Schlussfolgerung Der Nachweis neuroprotektiver Complement-Faktoren in der Perilymphe ist ein erster Schritt zur Untersuchung einer neuen Klasse von Biomolekülen im Innenohr. Unter den Effekten, die die neuroprotektiven Complement-Faktoren vermitteln, ist die Phosphorylierung von CREB und die Stabilisierung der Zellmembran durch die Regulierung des Cholesterin- und Lipid-Metabolismus zu nennen. Inwiefern sich hieraus Therapien für das Innenohr ableiten lassen, ist Gegenstand laufender Untersuchungen. Publication Date: 13 May 2021 (online) © . Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany